Inheris Biopharma

Nektar Therapeutics launches Inheris Biopharma
Pharmaceutical Business Review
Fri, 05/24/19 - 10:37 am
Nektar Therapeutics
Inheris Biopharma
CNS
In a change of plans, Nektar spins out its opioid into a new biotech subsidiary as FDA PDUFA date looms
Endpoints
Thu, 05/23/19 - 09:52 am
Nektar Therapeutics
spinoffs
NKTR-181
opioids
Inheris Biopharma